Clinical Trial 41006

Sherman Oaks, CA 91403

Study Summary:

California Neuroscience Research is conducting a research study of an investigational medication vs. placebo (an inactive substance) in participants who are between 60 and 75 and at increased risk for developing symptoms of Alzheimer’s Disease. Participation is voluntary.

Participant has one office visit (+ phone follow-ups) for genetic testing. For those that are at increased risk of developing Alzheimer’s Disease and meet other inclusion and exclusion criteria, there can be up to 8 years of treatment with an investigational medication or placebo.

Qualified Participants Must:

• Participants who are between 60 and 75 and at increased risk for developing symptoms of Alzheimer's Disease
• A study partner is required for the research study and must accompany the participant to some visits

Qualified Participants May Receive:

·         Study-related evaluation, genetic testing and genetic counseling

·         Study-related diagnostic and laboratory evaluations

·         Investigational medication  or placebo

·         Reimbursement for time and travel for participant and study partner

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.